Selective cox-2 inhibitors are used at increasingly higher doses in the US: A cause for concern? Annual European Congress of Rheumatology Singh, G., Mithal, A., Triadafilopoulos, G. BMJ PUBLISHING GROUP. 2005: 553–554

View details for Web of Science ID 000229909102494